Mereo BioPharma Group Stock (NASDAQ: MREO) stock price, news, charts, stock research, profile.
Open | $4.24 |
Close | $4.09 |
Volume / Avg. | 541.07K / 963.13K |
Day Range | $4.05 - $4.24 |
52 Wk Range | 1.07 - 5.02 |
Market Cap | $630.80M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 3.47% |
Days to Cover | 4.5 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Mereo BioPharma Group (NASDAQ:MREO) through any online brokerage.
Other companies in Mereo BioPharma Group’s space includes: Humacyte (NASDAQ:HUMA), 4D Molecular Therapeutics (NASDAQ:FDMT), Replimune Group (NASDAQ:REPL), Mesoblast (NASDAQ:MESO) and Opthea (NASDAQ:OPT).
Mereo BioPharma Group has a consensus price target of $6.80.
The stock price for Mereo BioPharma Group (NASDAQ: MREO) is $4.1 last updated September 23, 2024 at 6:52 PM EDT.
There are no upcoming dividends for Mereo BioPharma Group.
Mereo BioPharma Group’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
There is no upcoming split for Mereo BioPharma Group.
Mereo BioPharma Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.